Tiny nanobots offer a non-surgical solution for brain aneurysms
The Register - 07-Sep-2024Magnetic nanobots target brain aneurysms in rabbits, hinting at future human therapies
Join the club for FREE to access the whole archive and other member benefits.
Nanobots can be considered as the infantry of precision medicine. They're able to carry drugs to specific cells, hammer (literally!) their way into cells, and deliver their payload right where it hurts.
These tiny robots aren't (usually) miniaturised versions of industrial robots - as things work very different at the cellular level and in the blood that they travel in. Their movement is more akin to bacteria with wriggling tails or spinning corkscrews, either powered by sugar in the body or by magnetic fields that help guide them to their target. The smallest nanobots may be made of DNA that is formed into a cage-like structure containing a pharmaceutical package that is release when the target is reached.
The larger (relatively, they're still tiny!) nanobots have micro-legs to help them move crawl along organs inside the body, or contain cameras and sensors to transmit detailed physiological information back to your doctor to help take the guess work out of diagnosis.
Many futurists predict that before we're halfway into the 21st century we will be injecting ourselves with thousands of nanobots that patrol our bodies keeping an eye out for pathogens and diseases and then swarming together to defend the body against damage.
Magnetic nanobots target brain aneurysms in rabbits, hinting at future human therapies
Magnetic nanorobots could revolutionize medicine with precise internal treatments
The system works by being activated in acidic tumour environments
This approach uses algae-powered robots to neutralise harmful proteins in the colon
Click on resource name for more details.
The book that takes the reader from the fundamentals of nanobiology to the most advanced applications written by Ehud Gazit
DNA nanobots will soon be tried in a critically ill leukemia patient
Company specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor (LIF)
Quantum biology startup developing diagnostics for early cancer detection with a nanotechnology platform
Company that provides products addressing the field of magnetic nanoparticle research and applications